The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors of nuclear hormone receptor superfamily comprising of the following three subtypes: PPARα, PPARγ, and PPARβ/δ. Activation of PPAR-α reduces triglyceride level and is involved in regulation of energy homeostasis. Activation of PPAR-γ causes insulin sensitization and enhances glucose metabolism, whereas activation of PPAR- β/δ enhances fatty acids metabolism. Thus, PPAR family of nuclear receptors plays a major regulatory role in energy homeostasis and metabolic function. The present review critically analyzes the protective and detrimental effect of PPAR agonists in dyslipidemia, diabetes, adipocyte differentiation, inflammation, cancer, lung diseases, neurodegenerative disorders, fertility or reproduction, pain, and obesity.

Abstract licence: CC BY-NC-SA

40 more references, whose wording the paper’s licence keeps private.

• Cellular metabolism regulates the differentiation and function of T-cell subsets · 2024

• Microglia Phenotypes in Aging and Neurodegenerative Diseases · 2022

• Three decades of Cdk5 · 2021

• Targeting cancer stem cell pathways for cancer therapy · 2020

• Fatty Acid Synthase: An Emerging Target in Cancer · 2020

• Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments · 2020

• A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC‐derived microglia · 2019

• From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research · 2019

• TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts · 2019

• Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels · 2019

• Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis · 2018

• Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease · 2018

• Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism · 2017

• Antidiabetic properties of dietary flavonoids: a cellular mechanism review · 2015

• Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases · 2013

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.